Get started
TopgOptions

ADGI Potential Neutralizing Activity Against Covid-19 Variants

Long
TopgOptions  
NASDAQ:ADGI   None
Trend Analysis Technical Indicators Fundamental Analysis ADGI adagio adagiotherapeutics Coronavirus (COVID-19) covid19stock vaccine covidvaccine omicron
6
0
trendanalysis indicator fundamental adgi adagio adagiotherapeutics coronavirus covid19stock vaccine covidvaccine omicron
Adagio Therapeutics announced its lead monoclonal antibody has neutralization activity against the Omicron variant of SARS-CoV-2.

Adagio is evaluating ADG20 in its global Phase 2/3 clinical trials for prevention and treatment of COVID-19.

Adagio is engaging with the FDA regarding protocol updates to its global Phase 2/3 clinical trials.

My price target is the $14.5 resistance.

BUYSELL indicators tradingindicators.store/
TRADING COURSE bit.ly/tradex
Private Signals www.patreon.com/PremiumOptionsSignals
RESULTS www.bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
BYBIT partner.bybit.com/b/37880
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.